Literature DB >> 7908535

HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410.

Y Shindo1, H Inoko, T Yamamoto, S Ohno.   

Abstract

Vogt-Koyanagi-Harada's (VKH) disease is reported to be closely associated with the HLA class II antigen, HLA-DR4. Serologically defined DR4 is further divided into 11 alleles by molecular HLA genotyping. However, no study of HLA-DNA typing of VKH patients has been reported. To clarify molecular genetic mechanism underlying the susceptibility/resistance to VKH disease, HLA-DNA typing of DR antigens (DRB1 genotyping) by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was performed. It was found that DRB1*0405 showed a significant association with VKH disease compared with the healthy controls (corrected p value < 1 x 10(-5)) and that all the patients had DRB1*0405 and/or DRB1*0410. The specific amino acid residue shared only by these two alleles is Ser at position 57 which is located in the antigen binding groove and may influence the immunological function as an antigen-presenting molecule, suggesting that Ser at position 57 plays an important role in the susceptibility to VKH disease, although the possibility that the involvement of the HLA-DQ molecule, DQ4, in strong linkage disequilibrium with DRB1*0405 and DRB1*0410, cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908535      PMCID: PMC504742          DOI: 10.1136/bjo.78.3.223

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  24 in total

1.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

2.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

3.  Allelic variation in the DR subregion of the human major histocompatibility complex.

Authors:  J I Bell; D Denney; L Foster; T Belt; J A Todd; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

Review 4.  Genetics and expression of mouse Ia antigens.

Authors:  L Mengle-Gaw; H O McDevitt
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

Review 5.  Progress in understanding HLA and disease associations.

Authors:  J R Batchelor; A J McMichael
Journal:  Br Med Bull       Date:  1987-01       Impact factor: 4.291

6.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

7.  HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.

Authors:  J A Todd; J I Bell; H O McDevitt
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

8.  Vogt-Koyanagi-Harada syndrome.

Authors:  S Ohno; D H Char; S J Kimura; G R O'Connor
Journal:  Am J Ophthalmol       Date:  1977-05       Impact factor: 5.258

9.  Immunological aspects of Behçet's and Vogt-Koyanagi-Harada's diseases.

Authors:  S Ohno
Journal:  Trans Ophthalmol Soc U K       Date:  1981-09

Review 10.  Genetic complexity and expression of human class II histocompatibility antigens.

Authors:  A J Korman; J M Boss; T Spies; R Sorrentino; K Okada; J L Strominger
Journal:  Immunol Rev       Date:  1985-07       Impact factor: 10.983

View more
  31 in total

1.  Human risk allele HLA-DRB1*0405 predisposes class II transgenic Ab0 NOD mice to autoimmune pancreatitis.

Authors:  Tobias L Freitag; Candace Cham; Hsiang-Hsuan Sung; Georg F Beilhack; Ivana Durinovic-Belló; Salil D Patel; Roderick T Bronson; Detlef Schuppan; Grete Sønderstrup
Journal:  Gastroenterology       Date:  2010-03-18       Impact factor: 22.682

2.  Association of HLA genes with clinical outcomes of ANCA-associated vasculitis.

Authors:  Dong-yuan Chang; Huan Luo; Xu-jie Zhou; Min Chen; Ming-Hui Zhao
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-17       Impact factor: 8.237

Review 3.  Current approach in the diagnosis and management of panuveitis.

Authors:  Reema Bansal; Vishali Gupta; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

Review 4.  Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?

Authors:  Kenneth G-J Ooi; Grazyna Galatowicz; Virginia L Calder; Susan L Lightman
Journal:  Clin Med Res       Date:  2006-12

5.  Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells.

Authors:  Mary J Mattapallil; Phyllis B Silver; Joseph J Mattapallil; Reiko Horai; Zaruhi Karabekian; J Hugh McDowell; Chi-Chao Chan; Eddie A James; William W Kwok; H Nida Sen; Robert B Nussenblatt; Chella S David; Rachel R Caspi
Journal:  J Immunol       Date:  2011-07-15       Impact factor: 5.422

6.  Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients.

Authors:  D J Kilmartin; D Wilson; J Liversidge; A D Dick; J Bruce; R W Acheson; S J Urbaniak; J V Forrester
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

7.  HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia.

Authors:  Alia Iqniebi; Ameera Gaafar; Atia Sheereen; Abdullah Al-Suliman; Gamal Mohamed; Khaled Al-Hussein; Khalid F Tabbara
Journal:  Mol Vis       Date:  2009-09-12       Impact factor: 2.367

8.  A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients.

Authors:  Jean-Marie Tiercy; Sivakumar R Rathinam; Marianne Gex-Fabry; Edoardo Baglivo
Journal:  Mol Vis       Date:  2010-03-05       Impact factor: 2.367

9.  A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice.

Authors:  Giuseppina Pennesi; Mary J Mattapallil; Shu-Hui Sun; Dody Avichezer; Phyllis B Silver; Zaruhi Karabekian; Chella S David; Paul A Hargrave; J Hugh McDowell; W Clay Smith; Barbara Wiggert; Larry A Donoso; Chi-Chao Chan; Rachel R Caspi
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

10.  Evaluation of PTPN22 polymorphisms and Vogt-Koyanagi-Harada disease in Japanese patients.

Authors:  Yukihiro Horie; Nobuyoshi Kitaichi; Yoshihiko Katsuyama; Kazuhiko Yoshida; Toshie Miura; Masao Ota; Yuri Asukata; Hidetoshi Inoko; Nobuhisa Mizuki; Susumu Ishida; Shigeaki Ohno
Journal:  Mol Vis       Date:  2009-06-03       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.